Quick Answer
Bionano Genomics, Inc. reported R&D Expense of $11.37 million for fiscal year 2025.
Bionano Genomics, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $11.37M | -54.1% |
| 2024 | $24.80M | -54.1% |
| 2023 | $54.03M | +10.2% |
| 2022 | $49.05M | +118.1% |
| 2021 | $22.48M | +119.2% |
| 2020 | $10.26M | +12.9% |
| 2019 | $9.08M | -4.3% |
| 2018 | $9.48M | -21.0% |
| 2017 | $12.01M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.84M | -39.7% | -3.0% |
| June 30, 2025 | $2.93M | -57.1% | +23.7% |
| March 31, 2025 | $2.37M | -75.8% | -49.8% |
| September 30, 2024 | $4.72M | -65.8% | -30.9% |
| June 30, 2024 | $6.83M | -53.2% | -30.1% |
| March 31, 2024 | $9.78M | -29.8% | -29.1% |
| September 30, 2023 | $13.79M | +8.2% | -5.6% |
| June 30, 2023 | $14.61M | +24.2% | +4.8% |
- Bionano Genomics, Inc. showed a decrease of -54.1% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, Bionano Genomics, Inc.’s r&d expense has declined by 5.3% (from $12.01 million to $11.37 million).
- The most recent figure is from Bionano Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: